Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2000
09/28/2000WO2000056718A1 Imidazole compounds
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056353A2 A uro-genital condition treatment system
09/28/2000WO2000056349A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000042973A3 Homing pro-apoptotic conjugates and methods of using same
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/28/2000CA2367048A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365244A1 Calanolides for inhibiting btk
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT
09/27/2000EP1037883A1 NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
09/27/2000EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS
09/27/2000EP1037660A1 ribB
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037654A1 ribA
09/27/2000EP0733052B1 Bicyclene derivatives, their production and use
09/27/2000EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
09/27/2000EP0612216B1 Phospholipid antimicrobial compositions
09/27/2000CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors
09/27/2000CN1268061A Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
09/27/2000CN1267524A Kidney reinforcing medicine powder
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/27/2000CN1056775C Medicine for treating stone of curinary system
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124337 Treating male impotence by orally ingesting a mixture comprising a disintegrant to accelerate dissolution a phentolamine vasodilator effective within one hour prior to attempting sexual intercourse
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000CA2137832C Inhibitors of angiotensin i chymase(s) including human heart chymase
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055143A1 Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055129A1 Dithiocarbonimidate derivatives
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054815A2 Expression of dna or proteins in c. elegans
09/21/2000WO2000054808A1 Prostaglandin ep4 receptor agonist and treatment method
09/21/2000WO2000054784A1 Complex comprising the coordination compound manganese, its medical effects and the mode of its production
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000001668A3 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000CA2332427A1 Prostaglandin ep4 receptor agonist and treatment method
09/20/2000EP1036566A1 Preparation for continuous intravenous administration
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036093A1 Conjugates useful in the treatment of prostate cancer
09/20/2000EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1035851A2 Method for combating obesity
1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 562